Bernhard J. Woermann

1.5k total citations
22 papers, 482 citations indexed

About

Bernhard J. Woermann is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Bernhard J. Woermann has authored 22 papers receiving a total of 482 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hematology, 9 papers in Molecular Biology and 7 papers in Genetics. Recurrent topics in Bernhard J. Woermann's work include Acute Myeloid Leukemia Research (17 papers), Acute Lymphoblastic Leukemia research (5 papers) and Histone Deacetylase Inhibitors Research (5 papers). Bernhard J. Woermann is often cited by papers focused on Acute Myeloid Leukemia Research (17 papers), Acute Lymphoblastic Leukemia research (5 papers) and Histone Deacetylase Inhibitors Research (5 papers). Bernhard J. Woermann collaborates with scholars based in Germany, United States and New Zealand. Bernhard J. Woermann's co-authors include Wolfgang Hiddemann, Karsten Spiekermann, Wolfgang E. Berdel, Jan Braess, Eva Hoster, Tobias Herold, Stefan K. Bohlander, Annika Dufour, Michael Unterhalt and Christian Buske and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Bernhard J. Woermann

22 papers receiving 470 citations

Peers

Bernhard J. Woermann
Nils Winkelmann Germany
Dominique Mühlematter Switzerland
Alessia Tabarrini Italy
JM Hernández Spain
M. S. De Propris Italy
Svetlana Krichevsky Israel
Τατιάνα Τζένου Greece
J. Janssen Netherlands
Patrick Villarèse France
William A. Wyatt United States
Nils Winkelmann Germany
Bernhard J. Woermann
Citations per year, relative to Bernhard J. Woermann Bernhard J. Woermann (= 1×) peers Nils Winkelmann

Countries citing papers authored by Bernhard J. Woermann

Since Specialization
Citations

This map shows the geographic impact of Bernhard J. Woermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernhard J. Woermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernhard J. Woermann more than expected).

Fields of papers citing papers by Bernhard J. Woermann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernhard J. Woermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernhard J. Woermann. The network helps show where Bernhard J. Woermann may publish in the future.

Co-authorship network of co-authors of Bernhard J. Woermann

This figure shows the co-authorship network connecting the top 25 collaborators of Bernhard J. Woermann. A scholar is included among the top collaborators of Bernhard J. Woermann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernhard J. Woermann. Bernhard J. Woermann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Archer, Kellie J., Krzysztof Mrózek, Deedra Nicolet, et al.. (2024). Improving risk stratification for 2022 European LeukemiaNet favorable-risk patients with acute myeloid leukemia. The Innovation. 5(6). 100719–100719. 1 indexed citations
2.
Rausch, Christian, Maja Rothenberg‐Thurley, Annika Dufour, et al.. (2023). Validation and refinement of the 2022 European LeukemiaNet genetic risk stratification of acute myeloid leukemia. Leukemia. 37(6). 1234–1244. 45 indexed citations
3.
Rausch, Christian, Maja Rothenberg‐Thurley, Annika Dufour, et al.. (2022). Validation of the 2022 European Leukemianet Genetic Risk Stratification of Acute Myeloid Leukemia. Blood. 140(Supplement 1). 3408–3409. 3 indexed citations
4.
Konstandin, Nikola P., Friederike Pastore, Tobias Herold, et al.. (2018). Genetic heterogeneity of cytogenetically normal AML with mutations of CEBPA. Blood Advances. 2(20). 2724–2731. 38 indexed citations
5.
Janke, Hanna, Friederike Pastore, Tobias Herold, et al.. (2014). Activating FLT3 Mutants Show Distinct Gain-of-Function Phenotypes In Vitro and a Characteristic Signaling Pathway Profile Associated with Prognosis in Acute Myeloid Leukemia. PLoS ONE. 9(3). e89560–e89560. 50 indexed citations
6.
Pastore, Friederike, Philipp A. Greif, Stephanie Schneider, et al.. (2014). The NPM1 Mutation Type Has No Impact on Survival in Cytogenetically Normal AML. PLoS ONE. 9(10). e109759–e109759. 16 indexed citations
7.
Pastore, Friederike, Eva Hoster, Annika Dufour, et al.. (2014). Long-term follow-up of cytogenetically normal CEBPA-mutated AML. Journal of Hematology & Oncology. 7(1). 55–55. 34 indexed citations
8.
Greif, Philipp A., Nikola P. Konstandin, Klaus H. Metzeler, et al.. (2012). RUNX1 mutations in cytogenetically normal acute myeloid leukemia are associated with a poor prognosis and up-regulation of lymphoid genes. Haematologica. 97(12). 1909–1915. 66 indexed citations
9.
Stelljes, Matthias, Utz Krug, Dietrich W. Beelen, et al.. (2012). Allogeneic Stem Cell Transplantation Versus Conventional Postremission Therapy for Acute Myeloid Leukemia in First Complete Remission: A Matched Pairs Analysis. Blood. 120(21). 1974–1974. 1 indexed citations
10.
Lengfelder, Eva, Benjamin Hanfstein, Claudia Haferlach, et al.. (2011). Front Line Treatment of Elderly Patients with Acute Promyelocytic Leukemia: Long-Term Results of the German AML Cooperative Group. Blood. 118(21). 425–425. 2 indexed citations
11.
Schneider, Friederike, Eva Hoster, Michael Unterhalt, et al.. (2009). NPM1 but not FLT3-ITD mutations predict early blast cell clearance and CR rate in patients with normal karyotype AML (NK-AML) or high-risk myelodysplastic syndrome (MDS). Blood. 113(21). 5250–5253. 48 indexed citations
12.
13.
14.
Büchner, Thomas, Wolfgang E. Berdel, Claudia Schoch, et al.. (2005). Therapeutic outcome in prognostic subgroups of de-novo acute myeloid leukemia (AML) and the role of the age factor. A study in 1834 patients of 16 to 84 years. Journal of Clinical Oncology. 23(16_suppl). 6552–6552. 4 indexed citations
15.
Buechner, Thomas, Wolfgang E. Berdel, Claudia Schoch, et al.. (2005). Treatment of AML in biological subgroups. Hematology. 10(sup1). 281–285. 3 indexed citations
16.
17.
18.
Buechner, Thomas, W. Hiddemann, Michael Koenigsmann, et al.. (1990). Recombinant human GM-CSF following chemotherapy in high-risk AML.. PubMed. 6 Suppl 1. 131–4. 10 indexed citations
19.
Büchner, Thomas, Wolfgang Hiddemann, Michael Koenigsmann, et al.. (1990). Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor After Chemotherapy for Acute Leukemias at Higher Age or After Relapse. Hämatologie und Bluttransfusion. 33. 724–731. 5 indexed citations
20.
Hiddemann, W., et al.. (1981). Monitoring of leukemia by representative bone marrow cell kinetic analysis using biopsy material. 274. 504–508. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nils Winkelmann Breakdown of academic impact, for papers by Dominique Mühlematter Breakdown of academic impact, for papers by Alessia Tabarrini Breakdown of academic impact, for papers by JM Hernández Breakdown of academic impact, for papers by M. S. De Propris Breakdown of academic impact, for papers by Svetlana Krichevsky Breakdown of academic impact, for papers by Τατιάνα Τζένου Breakdown of academic impact, for papers by J. Janssen Breakdown of academic impact, for papers by Patrick Villarèse Breakdown of academic impact, for papers by William A. Wyatt
Rankless by CCL
2026